Abstract:AIM:Point mutation, one of the commonest gene mutations, is the most important molecular pathogenesis of cancer and chronic infection. The commonest methods for detection of point mutation are based on polymerase chain reaction (PCR). These techniques, however, cannot be used in large scale screening since they are neither accurate nor simple. For this reason, this study established a novel method of competitively differentiated PCR (CD-PCR) for screening point mutation in clinical practice.METHODS:Two competitively differentiated primers for mutant-type and wild-type templates respectively with an identically complemented region in 3' end except for last 2 base pairs and a different non-complemented region in 5' end were designed. Thus, competitive amplification might be carried out at a lower annealing temperature at first, and then differentiated amplification at a higher annealing temperature when primers could not combine with initial templates. The amplification was performed in one-tube. The products of CD-PCR were detected using microplate hybridization assay. CD-PCR was evaluated by detecting G1896A variant of hepatitis B virus (HBV) in form of recombinant plasmids and in sera from patients with hepatitis B, and compared with allele-specific PCR (AS-PCR) and competitive AS-PCR.RESULTS:CD-PCR was successfully established. It could clearly distinguish wild-type and mutant-type plasmid DNA of G1896A variant when the amount of plasmid DNA was between 10(2)-10(8)copies/reaction, while for AS-PCR and competitive AS-PCR, the DNA amount was between 10(2)-10(4)copies/reaction. CD-PCR could detect one copy of G1896A variant among 10-100 copies of wild-type plasmid DNA. The specificity of CD-PCR was higher than those of AS-PCR and competitive AS-PCR in the detection of HBV G1896A variant in sera from patients with hepatitis B. CD-PCR was independent of the amount of HBV DNA in serum. HBV G1896A variant was more often found in HBeAg (-) patients with a lower level of detectable viremia than that with a higher level of detectable viremia (P=0.0192).CONCLUSION:CD-PCR is more specific since it is less influenced by the amount of initial templates and the cross amplification between mutant- and wild-type amplified products. It is also simple and time-saving. Thus, CD-PCR might be useful in routine gene typing and point mutation screening. HBV G1896A or other more important mutations have to be routinely detected in patients with a detectable level of viremia after HBeAg/antibody conversion in clinical practice.

Methodological Improvement for PCR Amplification of the C/E1 Region in HCV Genome

Analysis of suspicious results of serum HBV DNA detected by fluorescence quantitative PCR

[Sequence Detection of HBV-DNA P and C Region in HIV/HBV Superinfection Subjects with Drug Resistance to HAART].

Optimization of Approach to Amplify Latent HIV-1 DNA Sequence

Establishment and application of polymerase chain reaction method for detection of interferon sensitivity determining region of hepatitis Cvirus

Establishment and application of a novel PCR assay for amplifying the full-length reverse transcriptase gene region of genotypes A～D of hepatitis B virus

Optimization of an assay method for Simian virus 40 nucleic acid sequence

A high frequency of GBV-C/HGV coinfection in hepatitis C patients in Germany.

To establish a new and simple method of genotyping of hepatitis B virus by PCR-RFLP to analysis on S region

Evaluation of Two Type-Specific Primers PCR Genotyping Methods of Hepatitis B Virus

Genotyping of Hepatitis C Virus Based on NS5B Region Sequence Analysis

A New and Sensitive Method for the Quantification of HBV Cccdna by Real-Time PCR

Establishment of RT-PCR Method for Diagnosing European-type PRRSV and Sequencing and Analysis of the ORF7 Gene

A New Approach for Sequencing Virion Genome of Chinese HIV-1 Strains Subtype B and BC from Plasma.

[Utilization of Uracil-DNA Glycosylase for Combining Reverse Transcription and Anti-Contamination with Polymerase Chain Reaction in Hepatitis C Virus].

Gene Mutation of Stop Coden in 3' Untranslated Region of Hepatitis C Virus

Novel Assay of Competitively Differentiated Polymerase Chain Reaction for Screening Point Mutation of Hepatitis B Virus.

Establishment and application of HCV genotyping based on NS5B region

Generation of Non-homologous Competitor DNA for Competitive Q uantitative PCR

Genetic Variability and Characterization of Non-Structural Region 5 of Hepatitis C Virus Genome from Chinese Patients

Application of PCR-RFLP in detection of adefovir dipivoxil resistance-associated mutations in hepatitis B virus